BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2021 1:09:16 PM | Browse: 536 | Download: 945
 |
Received |
|
2020-09-18 21:29 |
|
Peer-Review Started |
|
2020-09-18 21:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-01 17:53 |
|
Revised |
|
2020-12-02 17:07 |
|
Second Decision |
|
2020-12-10 11:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-12-14 04:50 |
|
Articles in Press |
|
2020-12-14 04:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-01-21 07:07 |
|
Publish the Manuscript Online |
|
2021-01-21 13:09 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Review |
| Article Title |
Emerging therapeutics in the management of COVID-19
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Asim Kichloo, Michael Albosta, Akshay Kumar, Michael Aljadah, Mohamed Mohamed, Zain El-Amir, Farah Wani, Shakeel Jamal, Jagmeet Singh and Akif Kichloo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michael Albosta, MD, Doctor, Doctor, Department of Internal Medicine, Central Michigan University, 1632 Stone Street, Saginaw, MI 48602, United States. albos1ms@cmich.edu |
| Key Words |
COVID-19; Therapeutics; Infectious disease; SARS-CoV-2; Pharmacology; Virology |
| Core Tip |
As coronavirus disease 2019 continues to affect the global community, researchers are working diligently to determine the efficacy of therapeutic agents to fight this virus in clinical trials. Currently, there is a lack of published literature that comprehensively discusses all of the therapeutic agents under investigation. In this manuscript, we provide readers with a thorough and comprehensive evaluation of the current state of therapeutics including the proposed mechanisms of action, pharmacokinetics, recommended dosages, adverse effects, and efficacy data from clinical trials. |
| Publish Date |
2021-01-21 13:09 |
| Citation |
Kichloo A, Albosta M, Kumar A, Aljadah M, Mohamed M, El-Amir Z, Wani F, Jamal S, Singh J, Kichloo A. Emerging therapeutics in the management of COVID-19. World J Virol 2021; 10(1): 1-29 |
| URL |
https://www.wjgnet.com/2220-3249/full/v10/i1/1.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v10.i1.1 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
